Affilogic is a private, French biotech company established in 2010. They are specialized in discovering and developing Nanofitins®.

Algenscribe is developing a new platform for Gene Replacement with its first applications in Gene Therapy and Oncology.

Apmonia Therapeutics is a biotechnology company dedicated to developing therapeutic strategies towards cancer.

AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.

Atlantic Bone Screen is a French CRO providing non-GLP preclinical services specialized in he field of osteoarticular indications / bone and joint diseases / biomaterials

AUROBAC THERAPEUTICS is a biopharmaceutical company aiming to develop the next generation of precision medicines and become leaders in the fight against bacterial infections, antimicrobial

AVEROA is an emerging company with a smart business focused on the development and registration of innovative drugs.

BIOASTER is the first Institute for Technological Innovation in Microbiology in France (Lyon and Paris, Pasteur Institute).

BIOPHTA is a French (FDA pre-IND transforming ophthalmology to relieve patients in the treatment of their eye diseases.

Brenus Pharma is a French clinical-stage biotech developing a pioneering discovery platform Stimulated-Tumor-Cell (STC) leading the path of a new generation of immunotherapies.

CEVIDRA is an independent pharmaceutical company which acts as a gateway to the French market for foreign companies.

Chelatec is recognized for its reliable expertise and offers a unique combination of custom radiolabeling, in vitro assays and in vivo investigations capabilities.

Developing its own assets coupled with a unique AI-driven approach, Cilcare focuses on cochlear synaptopathy treatment and associated neuro-inflammatory disorders.

Crossject SA is an emerging specialty pharma company, in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy.

Cynbiose is a preclinical CRO specialized in non-human primate (NHP) translational models for biomedical research since 2008.

Exeliom Biosciences is developing a new generation of immunotherapies based on therapeutic targets that play a critical role in our innate immunity.

Firalis Molecular Precision accelerates precision medicine by improving diagnostics, understanding disease mechanisms, and evaluating drug efficacy.

H.A.C. Pharma is a European pharmaceutical company incorporated in 2007 in France. H.A.C.

HORIANA is a premier consulting company dedicated to epidemiology and biostatistics, specializing in designing and conducting Healthcare Real-World Studies.

HTL Biotechnology is a world leader in the development and responsible bioproduction of pharmaceutical-grade biopolymers.

Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to chemical research.

Lys Therapeutics is a pioneering biotechnology company dedicated to addressing unmet medical needs in patients afflicted with neurovascular or neurodegenerative disorders.

MaaT Pharma is the leading microbiome company in oncology specialized in developing Microbiome Ecosystem Therapies dedicated to enhancing the survival of cancer patients.

MAbSilico is the TechBio pionner company specializing in computational solutions for discovering and designing therapeutic antibodies.

Netris Pharma is a clinical-stage company developing innovative therapeutics to improve treatment outcome for cancer patients.

Neuron Experts is a private CRO, createdin 2008, specialized in cultures of neurons mimicking neurodegenerative diseases.

NG BIOTECH make rapid diagnostics that improve healthcare outcomes within antimicrobial resistance, infectious disease, liver function, and women's health.

Nicox is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health.

Okomera specializes in automated 3D organoid screening technology that accelerates access to improved, precision-based cancer therapies.

Orakl Oncology stands at the forefront of the techbio landscape, pioneering the use of patient tumor avatars.

OSE Immunotherapeutics is an integrated Clinical Stage biotech company mastering complex biology with regards to T-cells and myeloid cells.

By understanding complex biology through artificial intelligence, Owkin integrates the best of human and AI capabilities to develop improved drugs and diagnostics at scale.

PEP-Therapy is a clinical-stage company developing first-in-class peptides as targeted therapies for the treatment of aggressive cancers.

Phost'in develops First-in-Class N-glycosylation inhibitors for the treatment of cancers and fibrosis (First-in-Human currently on-going in Europe for the first program).

PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants.

RD-Biotech is specialized in the supply of plasmid DNA, recombinant antibodies, and associated fragments, as well as monoclonal antibodies and recombinant proteins.

Roowin offers a large range of chemical services to support their customers and partners to advance their drug candidates from early research phase up to

Rosetta Omics pioneers precision medicine through tumor characterization using spatial multiomics, deep mass spectrometry and AI.

SEQENS is a global partner in health, personal care and specialty ingredients.

StromaCare is a biotech company specialized in discovering and developing new cancer treatments through their understanding of stromal tissue biology.

Founded with the goal of revolutionizing precision medicine, Surge is an innovative company specializing in in-depth understanding of the immune system using AI.

Syndivia is dedicated to enhancing treatment options for patients with solid tumors. They specialize in utilizing their proprietary and unique GeminiMab™ technology.

Theranexus is a French biopharmaceutical company discovering and developing treatments to meet the needs of patients with rare neurological disorders.

THERAVIA is a European-based company dedicated to the development, marketing, and distribution of products dedicated to serious conditions.

Vect-Horus is a privately held biotechnology company that designs and develops molecular vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs.

WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines.